Addex Pharmaceuticals SA raised CHF50.5 million (US$39.6 million) in what it called Europe's largest-ever Series B financing round for a biotechnology company. (BioWorld International)

Addex Pharmaceuticals SA raised CHF50.5 million (US$39.6 million) in what it called Europe's largest-ever Series B financing round for a biotechnology company. (BioWorld International)

Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. (BioWorld International)

Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. (BioWorld International)